Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections Article Corporate Partner REV NasoNeb Nasal Nebulizer MedInvent 02.21.14
Share |

Corporate Partner Spotlight:The NasoNeb® Nasal Nebulizer from MedInvent, LLC

Establish a NasoNeb Sinus Program and provide new treatment options to the multitude of sinus sufferers while creating a new revenue line for your compounding pharmacy.

The NasoNeb® Nasal Nebulizer delivers a high concentration of medication, with broad intranasal drug deposition and high intranasal drug retention. NasoNeb-delivered therapy is supported by peer-reviewed clinical data, including positive outcomes in a randomized, double-blinded, placebo-controlled study.

Broad intranasal deposition: The NasoNeb Nasal Nebulizer has been clinically-shown to deliver a high concentration of medication to all areas of the nasal and paranasal sinus cavities in pre- and post-operative patients*.



Positive outcomes data: In a recent peer-reviewed double-blinded, randomized clinical study; NasoNeb-delivered therapy demonstrated a statistically-significant 50 LPM improvement in the objective measure of Nasal Peak Inspiratory Flow (p≤0.005) from baseline to endpoint in the treatment arm*.

The NasoNeb System may avoid complications associated with sinus irrigations* as well as unintended pulmonary deposition from older-style devices derived from pulmonary nebulizers*.



FIGURE 1. Daily nasal peak inspiratory flow on treatment. Median values are depicted. The x-axis shows the study timeline with B = baseline measurement. *p ≤ 0.005 vs baseline for the group on budesonide.


The NasoNeb advantage: The patented NasoNeb Nasal Nebulizer advantage is a combination of droplet or particle size, airflow and fluid volume not found in any other device. Unlike medication irrigation, a high concentration of drug is delivered throughout the nasal and paranasal sinus cavities which stays in the nasal cavity and does not simply run down the sink.

  • The large particle size ensures the medication stays in the nasal cavity and out of the lungs
  • The right airflow drives the aerosol throughout the nasal and paranasal sinus cavities for broad deposition
  • The fluid volume ensures the medication stays in the nose and out of the sink for high intranasal drug retention.

This results in a controlled therapy delivery only to the nasal and paranasal sinus cavity. Delivery time is quick and the therapy is well tolerated. In a marketing survey, 4 out of 5 sinus sufferers who used NasoNeb for a month preferred NasoNeb to irrigation*.

Provide real solutions to a real problem: Sinus sufferers are not always adequately served by traditional pharmaceutical manufacturers. Topical therapies, compounded by pharmacists and delivered via the NasoNeb System, provide real treatment options for these patients.

Generate real revenue: A strategic sinus therapy program can bring more people to your pharmacy with the scientifically-backed NasoNeb System. MedInvent’s strategic programs, materials and resources will help ensure your clinical and commercial success.

Join the NasoNeb Pharmacy Network: Call us today at 1-866-960-9833 or visit our website at to learn how.

*References on file.

 Like us on facebook I 1-866-960-9833

Association Management Software Powered by YourMembership  ::  Legal